Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
Macular edema is the leading cause of visual impairment in patients with retinal vein occlusion. Limited improvements may be obtained with laser photocoagulation or intravitreal triamcinolone. However, according to the data provided by randomized clinical trials, intravitreal injections of ranibizum...
Main Authors: | Roberto Gallego-Pinazo, Rosa Dolz-Marco, Cristina Marín-Lambíes, Manuel Díaz-Llopis |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-01-01
|
Series: | Ophthalmology and Eye Diseases |
Online Access: | https://doi.org/10.4137/OED.S7264 |
Similar Items
-
Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
by: Roberto Gallego-Pinazo, et al.
Published: (2012-03-01) -
Safety and efficacy of single intravitreal injection of ranibizumab in macular edema secondary to recent nonischemic retinal vein occlusion
by: Walid Ibrahim
Published: (2017-01-01) -
Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema
by: Siddhi Goel, et al.
Published: (2019-01-01) -
Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion
by: Rajvardhan Azad, et al.
Published: (2012-01-01) -
Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
by: Alex Yuan, et al.
Published: (2014-02-01)